Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis, a Double-blind Multicenter Randomized-controlled Trial. OSOPOLAR Trial

NCT04924868 is registered in ClinicalTrials.gov with Hospital General Universitario de Alicante as lead sponsor.

NCT NCT04924868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04924868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis, a Double-blind Multicenter Randomized-controlled Trial. OSOPOLAR Trial
Lead sponsor
Hospital General Universitario de Alicante
Phase
Phase 3
Overall status
Recruiting
Start date
November 10, 2021
Completion date
July 1, 2027
Enrollment
332 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

acute pancreatitis due to gallstones